In Phase A, members will acquire diverse doses and schedules of oral ABBV-744 tablet to recognize Harmless dosing regimen. Additional contributors are going to be enrolled on the determined monotherapy dosign program. In Phase B, contributors will receive oral ruxolitinib and ABBV-744 might be offered as "insert-on" therapy. In Phase https://carderh555wit8.kylieblog.com/profile